Results 61 to 70 of about 9,858 (221)

Respiratory Support in the Emergency Department: An Updated Systematic Review and Meta‐Analysis

Worldviews on Evidence-Based Nursing, Volume 23, Issue 4, August 2026.
ABSTRACT Background An estimated 20% of emergency department (ED) patients require respiratory support (RS). Evidence suggests that nasal high flow (NHF) reduces RS need. Aims This is an update of a published review comparing NHF to non‐invasive ventilation (NIV) or to conventional oxygen therapy (COT) in adult ED patients.
Jane O'Donnell, Rebecca Fenn
wiley   +1 more source

Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2239-2249, July 2026.
Abstract Introduction Linezolid, a synthetic oxazolidinone for resistant gram‐positive infections, is generally associated with mild adverse effects such as gastrointestinal disturbances, but more serious reactions like lactic acidosis (LA) have also been reported.
Lina Naseralallah, Bodoor Aboujabal, Zahra Noureddine, Khaled Aboujabal, Somaya Koraysh   +4 more
wiley   +1 more source

High-flow nasal cannula (HFNC) support in interhospital transport of critically ill children [PDF]

, 2019
Purpose: Optimal respiratory support for interhospital transport of critically ill children is challenging and has been scarcely investigated. High-flow nasal cannula (HFNC) therapy has emerged as a promising support mode in the paediatric intensive care
Schlapbach, Luregn, Brady, Ann-Maree, Mayfield, Sara, Schibler, Andreas, Schaefer, Jonas   +4 more
core  

Diagnostic performance of ROX index cut-offs in determining HFNC failure.

, 2023
Diagnostic performance of ROX index cut-offs in determining HFNC failure.
Todspol Lertwattanachai (16412797), Konlawij Trongtrakul (12629744), Pruchwilai Nuchpramool (16412791), Piyarat Phairatwet (16412794), Sujaree Poopipatpab (8930363)   +4 more
core   +1 more source

Successful Management of Total Intravenous Anesthesia Using Remimazolam, Dexmedetomidine, and Remifentanil for Airway Stenting Under Rigid Bronchoscopy: A Case Report

Clinical Case Reports, Volume 14, Issue 7, July 2026.
Using intravenous general anesthesia with remimazolam and remifentanil, we successfully performed airway stent placement for cancer‐related airway stenosis without causing hypoxia. ABSTRACT During airway stenting for airway stenosis under rigid bronchoscopy, preservation of spontaneous breathing is desirable.
Yoko Kurihara, Maiko Hosokawa, Kiyoko Bito, Yusuke Ishida, Mariko Saito, Rena Fukura, Katsunori Oe   +6 more
wiley   +1 more source

Ratio of oxygen saturation index for predicting high-flow nasal cannula outcomes in emergency department for COVID-19 patients with severe hypoxemia: A retrospective study

Turkish Journal of Emergency Medicine
OBJECTIVES: High-flow nasal cannula (HFNC) oxygen therapy has been used as an initial ventilatory support for coronavirus disease 2019 (COVID-19) patients with mixed levels of acute hypoxemic respiratory failure (AHRF). However, the effectiveness of HFNC
Cynthia Karam, Ahmad Oseili, Fadia M Shebbo, Mohamad Fakih, Mohamad F El-Khatib   +4 more
doaj   +1 more source

Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial

BMJ Open Respiratory Research, 2020
Introduction Persistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO2 >7.0 kPa. Domiciliary high-flow nasal cannula
Line Hust Storgaard, Hans-Ulrich Hockey, Ulla Møller Weinreich   +2 more
doaj   +1 more source

Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19

Respiratory Research, 2022
Background High-flow nasal oxygen therapy (HFNC) may be an attractive first-line ventilatory support in COVID-19 patients. However, HNFC use for the management of COVID-19 patients and risk factors for HFNC failure remain to be determined.
Zakaria Ait Hamou, Nathan Levy, Julien Charpentier, Jean-Paul Mira, Matthieu Jamme, Mathieu Jozwiak   +5 more
doaj   +1 more source

Respiratory parameters within 7 days after the initiation of HFNC treatment.

, 2023
Respiratory parameters within 7 days after the initiation of HFNC treatment.
Todspol Lertwattanachai (16412797), Konlawij Trongtrakul (12629744), Pruchwilai Nuchpramool (16412791), Piyarat Phairatwet (16412794), Sujaree Poopipatpab (8930363)   +4 more
core   +1 more source

Non‐Linear Dysanaptic Lung Growth in Patients With Post‐Infectious Bronchiolitis Obliterans

Pediatric Pulmonology, Volume 61, Issue 7, July 2026.
ABSTRACT Introduction Few studies have assessed longitudinal pulmonary function outcomes in post‐infectious bronchiolitis obliterans (PIBO). This study analyzes pulmonary function changes from patients with PIBO at a single center with respect to time and inciting respiratory pathogen.
James M. Clegg, Ferdinand Cacho, Matthew D. McGraw, Michael G. O'Connor   +3 more
wiley   +1 more source